What is the recommended evaluation and management for a serum ferritin level of 260 ng/mL?

Evaluation and Management of Ferritin 260 ng/mL

A ferritin of 260 ng/mL requires measurement of transferrin saturation (TSAT) to determine if this represents true iron overload versus inflammation or other causes, as ferritin is an acute phase reactant and does not reliably indicate iron status in isolation at this level.

Initial Diagnostic Approach

The critical next step is obtaining a TSAT measurement 1. This single test determines your diagnostic pathway:

If TSAT ≥45%:

• Proceed to HFE genetic testing for hereditary hemochromatosis 2
• This combination (ferritin 260 ng/mL + TSAT ≥45%) suggests possible iron overload
• In hemochromatosis populations, ferritin >250 ng/mL in men and >200 ng/mL in women correlates with C282Y homozygosity in 77% and 56% respectively 2

If TSAT <45% (more likely scenario):

• This ferritin level likely reflects inflammation, metabolic syndrome, liver disease, or malignancy rather than iron overload 3, 4, 5
• Evaluate for:
  • Alcohol consumption (most common cause of secondary hyperferritinemia) 4
  • Metabolic syndrome components 4
  • Chronic inflammatory conditions 2
  • Liver disease (check ALT, AST) 2
  • Malignancy or infection 2

Context-Specific Interpretation

In Chronic Kidney Disease (CKD) Patients:

Ferritin 260 ng/mL falls within acceptable range for CKD patients on erythropoiesis-stimulating agents 1:

• Target range: 100-800 ng/mL 1
• This level suggests adequate iron stores for erythropoiesis
• No intervention needed if TSAT >20% and hemoglobin goals are met
• Continue monitoring every 3 months 1

In Hemodialysis Patients:

• Ferritin 260 ng/mL is appropriate and safe 1
• Maintain TSAT ≥20% and ferritin ≥100 ng/mL 1
• Avoid chronic TSAT >50% or ferritin >800 ng/mL to prevent iron overload 1
• Recent evidence suggests ferritin ≥132 ng/mL may associate with sarcopenia, though causality unclear 6

In Otherwise Healthy Individuals:

• Ferritin 260 ng/mL is mildly elevated but not diagnostic of hemochromatosis alone 2
• Must check TSAT - if <45%, iron overload is unlikely 2
• If TSAT ≥45%, genetic testing is mandatory 2

Critical Thresholds to Remember

Ferritin <1000 ng/mL accurately predicts absence of cirrhosis in hemochromatosis 2. At 260 ng/mL:

• No immediate concern for advanced liver disease
• No liver biopsy indicated 2
• If hemochromatosis confirmed, therapeutic phlebotomy can proceed without biopsy 2

Common Pitfalls

1. Do not assume iron overload based on ferritin alone - ferritin is an acute phase reactant and elevated in 40-70% of cases from multiple etiologies 3

2. Do not order genetic testing without checking TSAT first - this wastes resources and causes unnecessary patient anxiety 2

3. In CKD patients, do not withhold iron therapy based on ferritin 260 ng/mL if TSAT <20% and patient is anemic - functional iron deficiency can exist despite "normal" ferritin 1

4. Serial monitoring is essential - stability or decrease in ferritin over time reduces likelihood of iron overload disease 3

Monitoring Strategy

• Repeat ferritin and TSAT in 3-6 months if initial TSAT <45% and no clear inflammatory cause 3
• Stable or declining levels essentially rule out progressive iron overload
• Rising levels warrant genetic evaluation even if initial TSAT was <45%